cbdMD (YCBD) Cash from Investing Activities (2016 - 2025)
cbdMD (YCBD) reported Cash from Investing Activities of -$164802.0 for Q4 2025, little changed on a YoY basis from -$165219.1 in Q4 2024, and down 5777.39% sequentially from -$2804.0 in Q3 2025.
cbdMD (YCBD) Cash from Investing Activities (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Cash from Investing Activities data on file, last reported at -$164802.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities changed 0.25% year-over-year to -$164802.0; the trailing twelve-month figure through Dec 2025 stood at -$184587.0 (up 31.58% YoY), and the FY2025 full-year result was -$184172.0, up 36.5% from the prior year.
- Cash from Investing Activities retreated to -$164802.0 in Q4 2025, from -$2804.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.1 million in Q1 2023 to a low of -$2.0 million in Q3 2021.
- A 5-year average of -$190733.5 and a median of -$120180.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 921.25% in 2021, while the deepest fall reached 820.91% in 2021.
- Tracing YCBD's Cash from Investing Activities over 5 years: stood at -$231030.0 in 2021, then gained by 23.23% to -$177370.0 in 2022, then fell by 4.1% to -$184635.0 in 2023, then advanced by 10.97% to -$164387.0 in 2024, then fell by 0.25% to -$164802.0 in 2025.
- Business Quant data shows YCBD's Cash from Investing Activities at -$164802.0 in Q4 2025, -$2804.0 in Q3 2025, and -$1475.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -60.00 Mn |
| 10 | cbdMD | 4.72 Mn | 1.33 Mn | 3.00 Mn | -164,802.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -164,802.00 |
| Dec 31, 2025 | -164,802.00 |
| Sep 30, 2025 | -2,804.00 |
| Sep 30, 2025 | -2,804.00 |
| Jun 30, 2025 | -1,475.00 |
| Jun 30, 2025 | -1,475.00 |
| Mar 31, 2025 | -15,506.00 |
| Mar 31, 2025 | -15,506.00 |
| Dec 31, 2024 | -164,387.00 |
| Dec 31, 2024 | -164,387.00 |
| Sep 30, 2024 | -110,000.00 |
| Sep 30, 2024 | -110,000.00 |
| Mar 31, 2024 | 4,620.00 |
| Mar 31, 2024 | 4,620.00 |
| Dec 31, 2023 | -184,635.00 |
| Dec 31, 2023 | -184,635.00 |
| Sep 30, 2023 | -120,180.00 |
| Sep 30, 2023 | -120,180.00 |
| Jun 30, 2023 | -102,389.00 |
| Jun 30, 2023 | -102,389.00 |